Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Safety and Clinical Efficacy of Mitral Allografts in Patients With Primary Tricuspid Valve Disease Scheduled for Tricuspid Valve Replacement

NCT06196684 is registered in ClinicalTrials.gov with Chelyabinsk Regional Clinical Hospital as lead sponsor.

NCT NCT06196684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06196684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Safety and Clinical Efficacy of Mitral Allografts in Patients With Primary Tricuspid Valve Disease Scheduled for Tricuspid Valve Replacement
Lead sponsor
Chelyabinsk Regional Clinical Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
September 29, 2021
Completion date
October 30, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allografts, tricuspid valve insufficiency